5th Annual European Medical Device and Diagnostic Clinical Evidence Strategy Conference

Name: 5th Annual European Medical Device and Diagnostic Clinical Evidence Strategy Conference
Start: 2024-03-13T08:00:00
End: 2024-03-14T00:00:00
Location: Steigenberger Airport Hotel Berlin

13 Mar 2024

About the event

5th Annual European Medical Device and Diagnostic Clinical Evidence Strategy Conference 2024 brings back Europe’s most important conference focussed on developing effective and integrated strategies for clinical evidence. This two-day conference will have some of the best strategies on how to implement the pre-market and post-market data, addressing the practicalities of real-world sources for clinical data.

collection and much more. Presentations supported with real-life case studies and practical examples will provide deeper insight into the strategies for generating and collecting quality clinical data. This conference will provide attendees with an opportunity to participate in a highly interactive session.

Day1 08:00- 17.15 (CET) Day 2 08.30 – 15:40 (CET)

CPD Provider

TT LifeSciences

View member

Send an enquiry

Full Name*

Email Address*

Contact Number*

Industry*

Your Enquiry*

By submitting this form, you consent to CPD sending you email regarding your application.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Event Details

5th Annual European Medical Device and Diagnostic Clinical Evidence Strategy Conference

13 Mar 2024 08:0014 Mar 2024 00:00

Steigenberger Airport Hotel Berlin , Willy-Brandt-Platz 3, 12529 Schönefeld,

Get Directions

TT LifeSciences

TT LifeSciences develop and deliver strategic informational programmes through training courses, conferences and seminars aimed at tightly targeted audiences across a variety of industries. Our programmes address the needs of today’s leading executives across Europe, Middle East and Asia through timely and specific content. TT LifeSciences use extensive research from across the globe to consistently deliver essential content for those we serve.